Syncardia
Tucson, US · 1 known investors
Find your way into Syncardia
1 people in our graph share verified history with the Syncardia team — schools, employers, funds. One of them is your warm intro.
SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.
Founders & leadership
JG
Jack G. Copeland, M.D.Co-founder
JG
Jack G. Copeland
RG
Richard G. Smith
MJ
Marvin J. SlepianinFounder at Picard Medical, Inc.
MG
Michael GarippainExecutiveMichael Garippa held executive and board positions at multiple healthcare and medical device companies, including Syncardia and TandemHeart, and served as an independent director for a Costa Rican microfinance firm.
LB
Luis BurgosExecutive
DA
Douglas A. NutterExecutive
KC
Kirk CollamerinExecutive
Board
HG
Harry GeorgeBoard director
ES
Eric SalzmanBoard director
DD
Doug David FahouryBoard director
MC
Mark C. Goldberg, M.D.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 1 round · 2014
▶$6.4MraisedOct 2014 · 83 investors · Other Health CareRule 506(b)
▶$6.4MraisedOct 2014 · 83 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael GarippaExecutive Officer, Director
- Doug David FahouryDirector
- Mark C. Goldberg, M.D.Director
- Jack G. Copeland, M.D.Director
- Luis BurgosExecutive Officer
- Douglas A. NutterExecutive Officer
- Thomas K. CoxDirector
- Harry GeorgeDirector
- Kirk CollamerExecutive Officer
- Eric SalzmanDirector
- Offering amount
- $15M
- Amount sold
- $6.4M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Syncardia do?
- SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.
- Who founded Syncardia?
- Syncardia was founded by Jack G. Copeland, M.D., Jack G. Copeland, Richard G. Smith, Marvin J. Slepian.
- Who are Syncardia's investors?
- Syncardia's investors include Hunniwell Lake Ventures LLC.
- How much funding has Syncardia raised?
- Syncardia has disclosed $6.4M raised across 1 round.
- Where is Syncardia headquartered?
- Syncardia is headquartered in Tucson, US.